EP2110374A1
|
|
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
EP2058308A1
|
|
Benzimidazoledihydrothiadiazinone derivatives used as fructose-1,6-biphosphatase inhibitors and pharmaceutical compositions containing same.
|
EP1935420A1
|
|
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
EP1918285A1
|
|
Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
|
EP1801098A1
|
|
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
EP1754483A1
|
|
Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
|
EP1752450A1
|
|
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
|
EP1609786A1
|
|
5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids
|
EP1600446A1
|
|
New 3,3-dimethyl-5-cyano-benzoxepine derivatives useful for the preparation of 5-formyl-benzoxepine derivatives
|
EP1591434A1
|
|
New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
|
FR2865733A1
|
|
Thiazolylimidazole derivatives, processes for their preparation, pharmaceutical compositions containing them and medicine applications thereof
|
FR2864535A1
|
|
Quinoline acid derivatives and their therapeutic applications
|
FR2849598A1
|
|
Use of kynurenine-3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of cells of the langerhans islands
|
EP1535612A1
|
|
Treatment for hyperuricemia
|
FR2862966A1
|
|
Nitroso derivatives of diphenylamine.
|
FR2862964A1
|
|
Derivatives of diphenylamine.
|
FR2862965A1
|
|
Novel phenoxyacetamide derivatives and their use for the preparation of diphenylamides.
|
FR2862646A1
|
|
Novel antidiabetic compounds containing benzofuran, benzothiophenic derivatives
|
FR2862645A1
|
|
Antidiabetic compounds containing benzofuran, benzothiophenic derivatives
|
FR2859220A1
|
|
Promoter of fatp 5 human gene and uses thereof
|